About the OHF
Since 1989, the OHF has provided more than $10 million dollars for education, awareness and research for Primary Hyperoxaluria (PH).

The OHF tirelessly pursues its mission by supporting scientific research, which is dedicated to the understanding, discovery and development of potential new therapies while providing up to date information to industry and the public. In addition, OHF provides education, awareness, advocacy and global outreach by collaborating with partners to develop and expand the OHF’s resources, research and services.

Today, the OHF serves as the most viable resource for patients, families, professionals and those affected by PH.